Success Story: NIW Victory without RFE for an Immunology Expert from Indonesia

Posted by wegreened on April 8, 2026 in NIW, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

Client’s Testimonial:

“I'm really grateful for the opportunity to work with you and for all your help getting me there."

On February 11^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Student in the Field of Immunology (Approval Notice).

General Field: Immunology

Position at the Time of Case Filing: Student

Country of Origin: Indonesia

State of Residence at the Time of Filing: California

Approval Notice Date: February 11^th, 2026

Processing Time: 17 months, 20 days

Case Summary:

An EB-2 NIW petition was recently approved in over 17 months without RFE for a student with an M.S. in biology whose groundbreaking work in immunology and viral infection mechanisms has reshaped current understanding of viral immune responses and cellular therapy development.

Research Leadership and Global Recognition

The client has established expertise in immunology, becoming one of the leading specialists in understanding the molecular mechanisms underlying immune responses to viral infections. This work has advanced critical understanding of epigenetic remodeling of the innate and adaptive immune system in the context of immune memory formation. The researcher's scholarly record reflects a rare combination of productivity, impact, and scientific leadership

13 peer-reviewed journal articles (2 first-authored), 2 preprints (1 first-authored)
609 citations across global scientific communities.
Major research funding from organizations of exceptional national prestige, including the National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and National Institute of Allergy and Infectious Diseases (NIAID)

Expert Endorsements

To strengthen the NIW filing, our firm included expert recommendation letters. One expert has stated that:

"[Client]’s continuous work in immunology is undoubtedly of benefit to both the United States and global medical communities."

NIW Approval and Outlook

The client's NIW approval reflects USCIS's recognition of the client as a leading figure in immunology and infectious disease research. This approval validates the client's sustained impact, exceptional ability, and clear future benefit to the United States in advancing vaccine development, cellular therapy innovation, and public health protection.

It has been an honor to support this exceptional researcher throughout the petition process, and we extend our sincere best wishes for continued success in both professional and personal pursuits. We look forward to witnessing continued breakthroughs in immunology, vaccine development, and cellular therapy that will improve patient care and strengthen the nation's biomedical research enterprise for years to come.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%